|
|
Neurology Devices Market Outlook in Republic of Korea to 2016 - Neurostimulation Devices, Interventional Neurology and Others
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
|||||||||||
| Zahlen und Fakten zur Studie: |
Will be delivered within two days. 126 Pages | |||||||||||
| Inhalt der Studie: |
Introduction
GlobalData’s medical device report, “Neurology Devices Market Outlook in Republic of Korea to 2016 - Neurostimulation Devices, Interventional Neurology and Others” provides key market da.....
Introduction GlobalData’s medical device report, “Neurology Devices Market Outlook in Republic of Korea to 2016 - Neurostimulation Devices, Interventional Neurology and Others” provides key market data on the Republic of Korea Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within five market categories – CSF Management, Neurosurgical Products, Neurostimulation Devices, Interventional Neurology, and Radiosurgery. Segments include Hydrocephalus Shunts, Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Embolic Systems, Navigational Systems, CyberKnife Radiosurgery and Others. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Market size and company share data for Neurology Devices market categories – CSF Management, Neurosurgical Products, Neurostimulation Devices, Interventional Neurology, and Radiosurgery - Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within five market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016. Segments include Hydrocephalus Shunts, Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Embolic Systems, Navigational Systems, CyberKnife Radiosurgery and Others. - 2009 company shares and distribution shares data for each of the five market categories. - Global corporate-level profiles of key companies operating within the Republic of Korea Neurology Devices market. - Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Cordis Corporation, Cyberonics, Inc. and others. Highlights Reasons to buy - Develop business strategies by identifying the key market categories and segments poised for strong growth. - Explore investment opportunites in the market. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the competitive landscape. - Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize. Report Highlights Medtronic, Inc. Boston Scientific Corporation St. Jude Medical, Inc. Cyberonics, Inc. Cordis Corporation ev3 Inc. B. Braun Melsungen AG Integra LifeSciences Holdings Corporation KARL STORZ GmbH & Co. KG Terumo Corporation Codman & Shurtleff, Inc. [Studien Infos ausblenden] |
|||||||||||
|
TABLE OF CONTENTS 1 Table of Contents 2 1.1 List of Tables 7 1.2 List of Figures 9 2 Introduction 11 2.1 What is This Report About? 11 3 Neurology Devices In Republic of Korea 12 3.1 Neurology Devices, Market Segmentation 12 3.2 Neurology Devices, Republic of Korea, Overall Revenue ($m), 2002-2016 13 3.3 Neurology Devices Market, Republic of Korea, Revenue Mix ($m), 2009 15 3.4 Neurology Devices Market, Republic of Korea, Category Contribution (%), 2009 16 3.5 Neurology Devices, Republic of Korea, Category Volume (Units), 2002-2016 22 3.6 Neurology Devices, Republic of Korea, Company Share (2008-2009) 27 4 CSF Management In Republic of Korea 29 4.1 CSF Management, Market Segmentation 29 4.2 CSF Management Market, Republic of Korea, Revenue Mix ($m), 2009 30 4.3 CSF Management Market, Republic of Korea, Segment Contribution (%), 2009 31 4.4 CSF Management Overall Revenue (2002-2016) 32 4.5 CSF Management Overall Volume (2002-2016) 36 4.6 CSF Management Average Price (2002-2016) 40 4.7 CSF Management Distribution Share (2008-2009) 41 4.8 CSF Management, Republic of Korea, Company Share (2008-2009) 42 5 Interventional Neurology In Republic of Korea 44 5.1 Interventional Neurology, Market Segmentation 44 5.2 Interventional Neurology Market, Republic of Korea, Revenue Mix ($m), 2009 45 5.3 Interventional Neurology Market, Republic of Korea, Segment Contribution (%), 2009 46 5.4 Interventional Neurology Overall Revenue (2002-2016) 47 5.4.1 Embolic Systems, Revenue (2002-2016) 51 5.4.2 Navigational Systems, Revenue (2002-2016) 55 5.5 Interventional Neurology Overall Volume (2002-2016) 59 5.5.1 Embolic Systems, Volume (2002-2016) 63 5.5.2 Navigational Systems, Volume (2002-2016) 67 5.6 Interventional Neurology Average Price (2002-2016) 71 5.7 Interventional Neurology Distribution Share (2008-2009) 72 5.8 Interventional Neurology, Republic of Korea, Company Share (2008-2009) 73 6 Neurostimulation Devices In Republic of Korea 75 6.1 Neurostimulation Devices, Market Segmentation 75 6.2 Neurostimulation Devices Market, Republic of Korea, Revenue Mix ($m), 2009 76 6.3 Neurostimulation Devices Market, Republic of Korea, Segment Contribution (%), 2009 77 6.4 Neurostimulation Devices Overall Revenue (2002-2016) 78 6.5 Neurostimulation Devices Overall Volume (2002-2016) 82 6.6 Neurostimulation Devices Average Price (2002-2016) 86 6.7 Neurostimulation Devices Distribution Share (2008-2009) 87 6.8 Neurostimulation Devices, Republic of Korea, Company Share (2008-2009) 88 7 Neurosurgical Products In Republic of Korea 90 7.1 Neurosurgical Products Overall Revenue (2002-2016) 90 7.2 Neurosurgical Products Overall Volume (2002-2016) 92 7.3 Neurosurgical Products Average Price (2002-2016) 94 7.4 Neurosurgical Products Distribution Share (2008-2009) 95 7.5 Neurosurgical Products, Republic of Korea, Company Share (2008-2009) 96 8 Radiosurgery In Republic of Korea 98 8.1 Radiosurgery, Market Segmentation 98 8.2 Radiosurgery Overall Revenue (2002-2006) 99 8.3 Radiosurgery Overall Volume (2002-2006) 101 8.4 Radiosurgery Average Price (2002-2006) 102 9 Overview of Key Companies in Republic of Korea Neurology Devices Market 103 9.1 Medtronic, Inc. 103 9.1.1 Company Overview 103 9.1.2 Share in the Republic of Korea Neurology Devices Market 103 9.2 Boston Scientific Corporation 104 9.2.1 Company Overview 104 9.2.2 Share in the Republic of Korea Neurology Devices Market 104 9.3 St. Jude Medical, Inc. 105 9.3.1 Company Overview 105 9.3.2 Share in the Republic of Korea Neurology Devices Market 106 9.4 Cyberonics, Inc. 107 9.4.1 Company Overview 107 9.4.2 Share in the Republic of Korea Neurology Devices Market 107 9.5 Cordis Corporation 108 9.5.1 Company Overview 108 9.5.2 Share in the Republic of Korea Neurology Devices Market 108 9.6 ev3 Inc. 109 9.6.1 Company Overview 109 9.6.2 Share in the Republic of Korea Neurology Devices Market 109 9.7 B. Braun Melsungen AG 110 9.7.1 Company Overview 110 9.8 Integra LifeSciences Holdings Corporation 110 9.8.1 Company Overview 110 9.9 KARL STORZ GmbH & Co. KG 110 9.9.1 Company Overview 110 9.10 Terumo Corporation 111 9.10.1 Company Overview 111 9.11 Codman & Shurtleff, Inc. 111 9.11.1 Company Overview 111 10 Neurology Devices Market Pipeline Products 112 11 Financial Deals Landscape 116 11.1 Partnerships 116 11.1.1 Vycor Medical Enters Into Distribution Agreement With Devon Medical 116 12 Recent Developments 117 12.1 Strategy And Business Planning 117 12.1.1 Sep 02, 2010: Elekta Opens South Korean Office 117 12.2 Other Significant Developments 118 12.2.1 Jun 01, 2010: Neuro Kinetics Renews Relationship With Kwangwoo Medix 118 13 Appendix 119 13.1 Definitions of Markets Covered in the Report 120 13.1.1 Neurology Devices 120 13.2 Research Methodology 123 13.3 Secondary Research 123 13.4 Primary Research 124 13.5 Models 124 13.6 Forecasts 125 13.7 Expert Panels 125 13.8 GlobalData Consulting 125 13.9 Currency Conversion 125 13.10 Contact Us 126 13.11 Disclaimer 126 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
LIST OF TABLES 1.1 List of Tables Table 1: Neurology Devices, Republic of Korea, Overall Revenue ($m), 2002-2016 14 Table 2: Neurology Devices Market, Republic of Korea, Category Contribution (%), 2009 16 Table 3: Neurology Devices, Republic of Korea, Cross-Category Analysis, 2002-2016 17 Table 4: Neurology Devices, Republic of Korea, Overall Revenue ($m), Historic, 2002-2009 19 Table 5: Neurology Devices, Republic of Korea, Overall Revenue ($m), Forecast, 2009-2016 21 Table 6: Neurology Devices, Republic of Korea, Category Volume (Units), 2002-2016 22 Table 7: Neurology Devices, Republic of Korea, Category Volume (Units), Historic, 2002-2009 24 Table 8: Neurology Devices, Republic of Korea, Category Volume (Units), Forecast, 2009-2016 26 Table 9: Neurology Devices, Republic of Korea, Company Share by Revenue ($m), 2008-2009 28 Table 10: CSF Management Market, Republic of Korea, Segment Contribution (%), 2009 31 Table 11: CSF Management, Republic of Korea, Revenue ($m) by Segment, Historic, 2002-2009 33 Table 12: CSF Management, Republic of Korea, Revenue ($m) by Segment, Forecast, 2009-2016 35 Table 13: CSF Management, Republic of Korea, Volume (Units) by Segment, Historic, 2002-2009 37 Table 14: CSF Management, Republic of Korea, Volume (Units) by Segment, Forecast, 2009-2016 39 Table 15: CSF Management, Republic of Korea, Average Price ($), Historic, 2002-2009 40 Table 16: CSF Management, Republic of Korea, Average Price ($), Forecast, 2009-2016 40 Table 17: CSF Management, Republic of Korea, Distribution Share by Revenue ($m), 2008-2009 41 Table 18: CSF Management, Republic of Korea, Company Share by Revenue ($m), 2008-2009 43 Table 19: Interventional Neurology Market, Republic of Korea, Segment Contribution (%), 2009 46 Table 20: Interventional Neurology, Republic of Korea, Revenue ($m) by Segment, Historic, 2002-2009 48 Table 21: Interventional Neurology, Republic of Korea, Revenue ($m) by Segment, Forecast, 2009-2016 50 Table 22: Embolic Systems, Republic of Korea, Revenue ($m) by Sub-Segment, Historic, 2002-2009 52 Table 23: Embolic Systems, Republic of Korea, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 54 Table 24: Navigational Systems, Republic of Korea, Revenue ($m) by Sub-Segment, Historic, 2002-2009 56 Table 25: Navigational Systems, Republic of Korea, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 58 Table 26: Interventional Neurology, Republic of Korea, Volume (Units) by Segment, Historic, 2002-2009 60 Table 27: Interventional Neurology, Republic of Korea, Volume (Units) by Segment, Forecast, 2009-2016 62 Table 28: Embolic Systems, Republic of Korea, Volume (Units) by Sub-Segment, Historic, 2002-2009 64 Table 29: Embolic Systems, Republic of Korea, Volume (Units) by Sub-Segment, Forecast, 2009-2016 66 Table 30: Navigational Systems, Republic of Korea, Volume (Units) by Sub-Segment, Historic, 2002-2009 68 Table 31: Navigational Systems, Republic of Korea, Volume (Units) by Sub-Segment, Forecast, 2009-2016 70 Table 32: Interventional Neurology, Republic of Korea, Average Price ($), Historic, 2002-2009 71 Table 33: Interventional Neurology, Republic of Korea, Average Price ($), Forecast, 2009-2016 71 Table 34: Interventional Neurology, Republic of Korea, Distribution Share by Revenue ($m), 2008-2009 72 Table 35: Interventional Neurology, Republic of Korea, Company Share by Revenue ($m), 2008-2009 74 Table 36: Neurostimulation Devices Market, Republic of Korea, Segment Contribution (%), 2009 77 Table 37: Neurostimulation Devices, Republic of Korea, Revenue ($m) by Segment, Historic, 2002-2009 79 Table 38: Neurostimulation Devices, Republic of Korea, Revenue ($m) by Segment, Forecast, 2009-2016 81 Table 39: Neurostimulation Devices, Republic of Korea, Volume (Units) by Segment, Historic, 2002-2009 83 Table 40: Neurostimulation Devices, Republic of Korea, Volume (Units) by Segment, Forecast, 2009-2016 85 Table 41: Neurostimulation Devices, Republic of Korea, Average Price ($), Historic, 2002-2009 86 Table 42: Neurostimulation Devices, Republic of Korea, Average Price ($), Forecast, 2009-2016 86 Table 43: Neurostimulation Devices, Republic of Korea, Distribution Share by Revenue ($m), 2008-2009 87 Table 44: Neurostimulation Devices, Republic of Korea, Company Share by Revenue ($m), 2008-2009 89 Table 45: Neurosurgical Products, Republic of Korea, Revenue ($m), Historic, 2002-2009 90 Table 46: Neurosurgical Products, Republic of Korea, Revenue ($m) by Segment, Forecast, 2009-2016 91 Table 47: Neurosurgical Products, Republic of Korea, Volume (Units) by Segment, Historic, 2002-2009 92 Table 48: Neurosurgical Products, Republic of Korea, Volume (Units) by Segment, Forecast, 2009-2016 93 Table 49: Neurosurgical Products, Republic of Korea, Average Price ($), Historic, 2002-2009 94 Table 50: Neurosurgical Products, Republic of Korea, Average Price ($), Forecast, 2009-2016 94 Table 51: Neurosurgical Products, Republic of Korea, Distribution Share by Revenue ($m), 2008-2009 95 Table 52: Neurosurgical Products, Republic of Korea, Company Share by Revenue ($m), 2008-2009 97 Table 53: Radiosurgery, Republic of Korea, Revenue ($m) by Segment, Historic, 2002-2006 100 Table 54: Radiosurgery, Republic of Korea, Volume (Units) by Segment, Historic, 2002-2006 101 Table 55: Radiosurgery, Republic of Korea, Average Price ($), Historic, 2002-2006 102 Table 56: Neurology Devices Market Pipeline Products 112 Table 57: Vycor Medical Enters Into Distribution Agreement With Devon Medical 116 Table 58: USD to Local Currency, Republic of Korea, Average Actual Rate 2002-2009 125 LIST OF FIGURES 1.2 List of Figures Figure 1: Neurology Devices, Market Segmentation 12 Figure 2: Neurology Devices, Republic of Korea, Overall Revenue ($m), 2002-2016 13 Figure 3: Neurology Devices Market, Republic of Korea, Revenue Mix ($m), 2009 15 Figure 4: Neurology Devices Market, Republic of Korea, Category Contribution (%), 2009 16 Figure 5: Neurology Devices, Republic of Korea, Cross-Category Analysis, 2002-2016 17 Figure 6: Neurology Devices, Republic of Korea, Overall Revenue ($m), Historic, 2002-2009 18 Figure 7: Neurology Devices, Republic of Korea, Overall Revenue ($m), Forecast, 2009-2016 20 Figure 8: Neurology Devices, Republic of Korea, Category Volume (Units), 2002-2016 22 Figure 9: Neurology Devices, Republic of Korea, Category Volume (Units), Historic, 2002-2009 23 Figure 10: Neurology Devices, Republic of Korea, Category Volume (Units), Forecast, 2009-2016 25 Figure 11: Neurology Devices, Republic of Korea, Company Share (%), 2009 27 Figure 12: CSF Management, Market Segmentation 29 Figure 13: CSF Management Market, Republic of Korea, Revenue Mix ($m), 2009 30 Figure 14: CSF Management Market, Republic of Korea, Segment Contribution (%), 2009 31 Figure 15: CSF Management, Republic of Korea, Revenue ($m) by Segment, Historic, 2002-2009 32 Figure 16: CSF Management, Republic of Korea, Revenue ($m) by Segment, Forecast, 2009-2016 34 Figure 17: CSF Management, Republic of Korea, Volume (Units) by Segment, Historic, 2002-2009 36 Figure 18: CSF Management, Republic of Korea, Volume (Units) by Segment, Forecast, 2009-2016 38 Figure 19: CSF Management, Republic of Korea, Company Share (%), 2009 42 Figure 20: Interventional Neurology, Market Segmentation 44 Figure 21: Interventional Neurology Market, Republic of Korea, Revenue Mix ($m), 2009 45 Figure 22: Interventional Neurology Market, Republic of Korea, Segment Contribution (%), 2009 46 Figure 23: Interventional Neurology, Republic of Korea, Revenue ($m) by Segment, Historic, 2002-2009 47 Figure 24: Interventional Neurology, Republic of Korea, Revenue ($m) by Segment, Forecast, 2009-2016 49 Figure 25: Embolic Systems, Republic of Korea, Revenue ($m) by Sub-Segment, Historic, 2002-2009 51 Figure 26: Embolic Systems, Republic of Korea, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 53 Figure 27: Navigational Systems, Republic of Korea, Revenue ($m) by Sub-Segment, Historic, 2002-2009 55 Figure 28: Navigational Systems, Republic of Korea, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 57 Figure 29: Interventional Neurology, Republic of Korea, Volume (Units) by Segment, Historic, 2002-2009 59 Figure 30: Interventional Neurology, Republic of Korea, Volume (Units) by Segment, Forecast, 2009-2016 61 Figure 31: Embolic Systems, Republic of Korea, Volume (Units) by Sub-Segment, Historic, 2002-2009 63 Figure 32: Embolic Systems, Republic of Korea, Volume (Units) by Sub-Segment, Forecast, 2009-2016 65 Figure 33: Navigational Systems, Republic of Korea, Volume (Units) by Sub-Segment, Historic, 2002-2009 67 Figure 34: Navigational Systems, Republic of Korea, Volume (Units) by Sub-Segment, Forecast, 2009-2016 69 Figure 35: Interventional Neurology, Republic of Korea, Company Share (%), 2009 73 Figure 36: Neurostimulation Devices, Market Segmentation 75 Figure 37: Neurostimulation Devices Market, Republic of Korea, Revenue Mix ($m), 2009 76 Figure 38: Neurostimulation Devices Market, Republic of Korea, Segment Contribution (%), 2009 77 Figure 39: Neurostimulation Devices, Republic of Korea, Revenue ($m) by Segment, Historic, 2002-2009 78 Figure 40: Neurostimulation Devices, Republic of Korea, Revenue ($m) by Segment, Forecast, 2009-2016 80 Figure 41: Neurostimulation Devices, Republic of Korea, Volume (Units) by Segment, Historic, 2002-2009 82 Figure 42: Neurostimulation Devices, Republic of Korea, Volume (Units) by Segment, Forecast, 2009-2016 84 Figure 43: Neurostimulation Devices, Republic of Korea, Company Share (%), 2009 88 Figure 44: Neurosurgical Products, Republic of Korea, Revenue ($m), Historic, 2002-2009 90 Figure 45: Neurosurgical Products, Republic of Korea, Revenue ($m) by Segment, Forecast, 2009-2016 91 Figure 46: Neurosurgical Products, Republic of Korea, Volume (Units) by Segment, Historic, 2002-2009 92 Figure 47: Neurosurgical Products, Republic of Korea, Volume (Units) by Segment, Forecast, 2009-2016 93 Figure 48: Neurosurgical Products, Republic of Korea, Company Share (%), 2009 96 Figure 49: Radiosurgery, Market Segmentation 98 Figure 50: Radiosurgery, Republic of Korea, Revenue ($m) by Segment, Historic, 2002-2006 99 Figure 51: Radiosurgery, Republic of Korea, Volume (Units) by Segment, Historic, 2002-2006 101 Figure 52: Medtronic, Inc., Company Share (%),Republic of Korea Neurology Devices Market, 2009 103 Figure 53: Boston Scientific Corporation, Company Share (%),Republic of Korea Neurology Devices Market, 2009 104 Figure 54: St. Jude Medical, Inc., Company Share (%),Republic of Korea Neurology Devices Market, 2009 106 Figure 55: Cyberonics, Inc., Company Share (%),Republic of Korea Neurology Devices Market, 2009 107 Figure 56: Cordis Corporation, Company Share (%),Republic of Korea Neurology Devices Market, 2009 108 Figure 57: ev3 Inc., Company Share (%),Republic of Korea Neurology Devices Market, 2009 109 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||


